The Effect of High vs. Moderate Protein Consumption on Human Health

NCT04156165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2021-11-01

No results posted yet for this study

Summary

The study will be conducted as a parallel randomized controlled intervention trial, initiated by eight weeks rapid weight loss with one of two VLCDs, one week of reintroducing regular foods, and 12 weeks with one of two different ad libitum diets; in total 21 weeks. The study will be blinded for the statistician. Due to obvious different dietary intakes in the two diets, subjects cannot be blinded and neither the study personnel. As the study includes different dietary recommendations the registered clinical dietician advising the subjects cannot be blinded either.

In total 110 overweight and obese volunteers will be included.

Conditions

Interventions

DIETARY_SUPPLEMENT

VLCD-Active

Lighter life formula products supplied to subjects, four sachets pr day. Dietetic advise given regularly.

OTHER

Maintenance-Active

Weight loss maintenance diet with high protein and low glycemic index and load, high in fiber and whole grain, daily including 150 g minced beef.

DIETARY_SUPPLEMENT

VLCD-Control

Lighter life VLCD products

OTHER

Maintenance-Control

Weight loss maintenance diet with moderate protein and low glycemic index and load, high in fiber and whole grain, daily including 25 g minced beef.

Sponsors & Collaborators

  • US National Cattlemen´s Association

    collaborator UNKNOWN
  • Danish Agriculture and Food Counsel

    collaborator UNKNOWN
  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Arne Astrup, Professor · Department of Nutrition, Exercise and Sports, UCPH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-11-10
Completion
2020-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04156165 on ClinicalTrials.gov